These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 12296287
21. Therapy of Behçet's disease. Kötter I, Dürk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M. Ger J Ophthalmol; 1996 Mar; 5(2):92-7. PubMed ID: 8741153 [Abstract] [Full Text] [Related]
23. Cyclosporin-A therapy in severe uveitis of Behçet's disease. Süllü Y, Oge I, Erkan D, Aritürk N, Mohajeri F. Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443 [Abstract] [Full Text] [Related]
24. Behçet's syndrome: from aetiology to treatment. Powell RJ. Adv Exp Med Biol; 2003 Feb; 528():481-6. PubMed ID: 12918749 [No Abstract] [Full Text] [Related]
25. Use of colchicine in Behçet's syndrome. Sander HM, Randle HW. Cutis; 1986 May; 37(5):344-8. PubMed ID: 3519102 [Abstract] [Full Text] [Related]
26. [Treatment of Behçet's disease with immunosuppressive agents and colchicine (author's transl)]. Kadoya M, Okinami S. Nippon Ganka Gakkai Zasshi; 1979 Mar; 83(3):200-6. PubMed ID: 484365 [No Abstract] [Full Text] [Related]
27. Azathioprine in Behcet's syndrome: effects on long-term prognosis. Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tüzün Y, Senocak M, Yazici H. Arthritis Rheum; 1997 Apr; 40(4):769-74. PubMed ID: 9125262 [Abstract] [Full Text] [Related]
29. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Adler YD, Mansmann U, Zouboulis CC. Dermatology; 2001 Apr; 203(4):322-4. PubMed ID: 11752821 [Abstract] [Full Text] [Related]
30. Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series. Ciancio G, Colina M, La Corte R, Lo Monaco A, De Leonardis F, Trotta F, Govoni M. Rheumatology (Oxford); 2010 Mar; 49(3):501-4. PubMed ID: 20015973 [Abstract] [Full Text] [Related]
31. Immunotherapy for Behçet's disease. Mochizuki M. Int Rev Immunol; 1997 Mar; 14(1):49-66. PubMed ID: 9203026 [Abstract] [Full Text] [Related]
32. The management of Behçet's syndrome: how are we doing? Yazici H, Yurdakul S, Hamuryudan V. Clin Exp Rheumatol; 1999 Mar; 17(2):145-7. PubMed ID: 10342039 [No Abstract] [Full Text] [Related]
33. Azathioprine in severe uveitis of Behçet's disease. Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi Huong D, Resche-Rigon M, Cassoux N, Le Hoang P, Amoura Z, Bodaghi B, Cacoub P. Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1733-8. PubMed ID: 20665749 [Abstract] [Full Text] [Related]
34. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases]. Niessen F, Campinchi R, Bloch-Michel E. J Fr Ophtalmol; 1982 Dec; 5(6-7):407-16. PubMed ID: 7130629 [No Abstract] [Full Text] [Related]
35. Clinical response to thalidomide and colchicine in two siblings with Behcet's disease carrying a single mutated MEFV allele. Rigante D, La Torre F, Calcagno G, Falcini F. Rheumatol Int; 2012 Jun; 32(6):1859-60. PubMed ID: 21833519 [No Abstract] [Full Text] [Related]
37. Clinical-radiological correlation in the evolution of a neuro-Behçet's syndrome: case report. Amrom D, Buisseret T. Eur Neurol; 1991 Jun; 31(6):419-22. PubMed ID: 1756770 [No Abstract] [Full Text] [Related]
39. Behçet's disease and hypopituitarism: a possible link. Labib M, Haddon A, Delamere J. Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():506-7. PubMed ID: 7832577 [No Abstract] [Full Text] [Related]
40. Neuro-Behçet syndrome presenting as acute meningeal syndrome. Kara B, Somer A, Pişkin S, Aydinli N, Salman N, Yalçin I. J Infect; 2006 Apr; 52(4):e120-3. PubMed ID: 16197999 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]